Floatz logo

NEPENTHE

Bariatric Surgical Pain

IVO JURISICSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

11 Active assets in the Bariatric Surgical Pain cohort.

Asset / SponsorPhaseRating
RAMIFENTANYL
IVO JURISIC
N/AD
Granisetron
IVO JURISIC
N/AD
Meperidine
IVO JURISIC
N/AD
FENTANYL
IVO JURISIC
N/AD
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
IVO JURISIC
N/AD

View all 11 →

Same molecule, other indications

NEPENTHE is also rated in:

PainDormant
BBB
Indicative ·
77 / 100
View asset →
cancer of unknown primary siteDormant
BBB
Indicative ·
75 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →